fluconazole has been researched along with Lymphoma in 22 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of oral fluconazole versus a polyene regimen in preventing mycoses in neutropenic patients was compared." | 5.07 | Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. ( Burnie, J; Clink, H; Ellis, ME; Ernst, P; Greer, W; Halim, MA; Hussain Qadri, SM; Kalin, M; Padmos, A; Spence, D, 1994) |
| "Efficacies of fluconazole (FLCZ) were evaluated in 8 cases of systemic mycosis (1 case each of candidemia, candiduria, 4 cases of pulmonary candidiasis, and 2 cases of suspected fungemia) complicated in immunocompromised children." | 5.07 | [A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children]. ( Hatae, Y; Ishikawa, A; Ishikawa, Y; Matsumoto, S; Sakiyama, Y; Shimizu, T; Takase, A; Takeda, T; Wagatsuma, Y, 1994) |
| "Efficacy of fluconazole (FLCZ), an anti-fungal agent of triazole derivatives, was evaluated in patients with systemic mycoses and suspected mycoses associated with hematologic malignancies including leukemia, myelodysplastic syndrome and malignant lymphoma." | 3.68 | [Efficacy of fluconazole on systemic mycosis associated with hematologic malignancies and a study on diagnostic value of plasma beta-D-glucan levels]. ( Hirakawa, K; Horiike, S; Kashima, K; Kuzuyama, Y; Misawa, S; Nakai, H; Seryu, T; Takashima, T; Taniwaki, M; Tsuda, S, 1993) |
| "Fungal infections are a major problem in patients with hematologic malignancy." | 2.68 | Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. ( Schaffner, A; Schaffner, M, 1995) |
| "Two different flucytosine (5-FC) treatment regimens, one by itself and the other in combination with fluconazole (FLCZ) were compared in chemotherapy against mycotic infections in 60 patients with hematological diseases." | 2.67 | [A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method]. ( Ariyoshi, H; Hamajima, N; Hotta, T; Kodera, Y; Murate, T; Naito, K; Naoe, T; Ogura, M; Saito, H; Tanaka, M, 1994) |
| "Fluconazole (FLCZ) was administered orally or intravenously to 161 patients with systemic fungal infections complicated with hematological disorders and it was possible to evaluate clinical efficacies in 109 patients." | 2.67 | [Clinical study of fluconazole for systemic fungal infections with hematological disorders]. ( Aoki, I; Kitamura, S; Miyakawa, K; Ohbayashi, Y; Sato, H; Shindo, E; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y, 1993) |
| " However, the ideal dosage of fluconazole has never been tested." | 1.48 | A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling. ( Bramanti, S; Carlo-Stella, C; Casari, E; Castagna, L; Crocchiolo, R; De Philippis, C; Mariotti, J; Morabito, L; Pocaterra, D; Rimondo, A; Santoro, A; Sarina, B; Tordato, F, 2018) |
| "The clinical context of underlying malignancy and hospitalization in ICU may be relevant to the initial management of candidemia." | 1.46 | The risk and clinical outcome of candidemia depending on underlying malignancy. ( Bretagne, S; Desnos-Ollivier, M; Dromer, F; Lortholary, O; Renaudat, C; Sitbon, K, 2017) |
| "Fluconazole is considered to be a potent, safe antifungal agent for the treatment of suspected fungal infections associated with hematological diseases." | 1.29 | [Clinical efficacy of fluconazole against fungal infections in hematological diseases]. ( Asahara, F; Hisano, S; Kawasaki, C; Kimura, N; Morioka, E; Nagano, M; Nakashima, H; Okumura, M; Suzumiya, J; Uchida, T; Yoshida, T, 1996) |
| "Fluconazole (FLCZ) was administrated 100-400 mg/day intravenously or orally to 79 patients with systemic fungal infections complicated with hematological disorders and it was possible to evaluate clinical efficacies in 60 patients." | 1.29 | [A clinical evaluation of fluconazole in deep seated fungal infections associated with hematological disorders]. ( Asano, Y; Eto, S; Ikeda, K; Izumi, Y; Misago, M; Mori, N; Morimoto, I; Murakami, S; Nagata, K; Nakanishi, M; Nakata, K; Oda, E; Oda, S; Ogawa, R; Ohkuma, K; Ohmori, F; Ohnishi, Y; Sawada, H; Tanaka, H; Tohnai, S; Tsukada, J; Wake, A; Yamamura, M; Yamano, Y; Yamasaki, Y, 1996) |
| " No significant adverse reactions nor abnormality in clinical laboratory tests related with the dosing of fluconazole were observed in any of the patients." | 1.28 | [A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy]. ( Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 12 (54.55) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Schattner, A | 1 |
| Finn, T | 1 |
| Glick, Y | 1 |
| Lortholary, O | 1 |
| Renaudat, C | 1 |
| Sitbon, K | 1 |
| Desnos-Ollivier, M | 1 |
| Bretagne, S | 1 |
| Dromer, F | 1 |
| Sarina, B | 1 |
| Mariotti, J | 1 |
| Bramanti, S | 1 |
| Morabito, L | 1 |
| Crocchiolo, R | 1 |
| Rimondo, A | 1 |
| Tordato, F | 1 |
| Pocaterra, D | 1 |
| Casari, E | 1 |
| De Philippis, C | 1 |
| Carlo-Stella, C | 1 |
| Santoro, A | 1 |
| Castagna, L | 1 |
| Manning, MA | 1 |
| Kuo, PH | 1 |
| Yeager, AM | 1 |
| Trpković, A | 1 |
| Pekmezović, M | 1 |
| Barać, A | 1 |
| Crnčević Radović, L | 1 |
| Arsić Arsenijević, V | 1 |
| Takaoka, K | 1 |
| Nannya, Y | 1 |
| Shinohara, A | 1 |
| Arai, S | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Sakamoto, N | 1 |
| Maeda, T | 1 |
| Mikita, K | 1 |
| Kato, Y | 1 |
| Yanagisawa, N | 1 |
| Suganuma, A | 1 |
| Imamura, A | 1 |
| Nakamura-Uchiyama, F | 1 |
| Miyahira, Y | 1 |
| Kawana, A | 1 |
| Ohnishi, K | 1 |
| Ajisawa, A | 1 |
| Cannella, AP | 1 |
| Vinetz, JM | 1 |
| Schaffner, A | 1 |
| Schaffner, M | 1 |
| Naito, K | 1 |
| Murate, T | 1 |
| Hotta, T | 1 |
| Saito, H | 1 |
| Hamajima, N | 1 |
| Naoe, T | 1 |
| Ogura, M | 1 |
| Ariyoshi, H | 1 |
| Tanaka, M | 1 |
| Kodera, Y | 1 |
| Ellis, ME | 1 |
| Clink, H | 1 |
| Ernst, P | 1 |
| Halim, MA | 1 |
| Padmos, A | 1 |
| Spence, D | 1 |
| Kalin, M | 1 |
| Hussain Qadri, SM | 1 |
| Burnie, J | 1 |
| Greer, W | 1 |
| Ishikawa, Y | 1 |
| Shimizu, T | 1 |
| Sakiyama, Y | 1 |
| Matsumoto, S | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Ishikawa, A | 1 |
| Takase, A | 1 |
| Wagatsuma, Y | 1 |
| Tsuda, S | 1 |
| Misawa, S | 1 |
| Horiike, S | 1 |
| Hirakawa, K | 1 |
| Kuzuyama, Y | 1 |
| Nakai, H | 1 |
| Seryu, T | 1 |
| Takashima, T | 1 |
| Taniwaki, M | 1 |
| Kashima, K | 1 |
| Kitamura, S | 1 |
| Miyakawa, K | 1 |
| Wakabayashi, Y | 1 |
| Urabe, A | 1 |
| Sato, H | 1 |
| Ohbayashi, Y | 1 |
| Takaku, F | 1 |
| Togawa, A | 1 |
| Shindo, E | 1 |
| Aoki, I | 1 |
| Huijgens, PC | 1 |
| van Loenen, AC | 1 |
| Simoons-Smit, AM | 1 |
| Prooy, E | 1 |
| Ossenkoppele, GJ | 1 |
| Girmenia, C | 1 |
| Martino, P | 1 |
| Cassone, A | 1 |
| Morioka, E | 1 |
| Asahara, F | 1 |
| Nagano, M | 1 |
| Kawasaki, C | 1 |
| Yoshida, T | 1 |
| Uchida, T | 1 |
| Nakashima, H | 1 |
| Suzumiya, J | 1 |
| Kimura, N | 1 |
| Hisano, S | 1 |
| Okumura, M | 1 |
| Murakami, S | 1 |
| Misago, M | 1 |
| Tohnai, S | 1 |
| Nakanishi, M | 1 |
| Ogawa, R | 1 |
| Wake, A | 1 |
| Nagata, K | 1 |
| Mori, N | 1 |
| Tsukada, J | 1 |
| Nakata, K | 1 |
| Oda, S | 1 |
| Morimoto, I | 1 |
| Eto, S | 1 |
| Izumi, Y | 1 |
| Sawada, H | 1 |
| Yamasaki, Y | 1 |
| Yamano, Y | 1 |
| Ohmori, F | 1 |
| Ohkuma, K | 1 |
| Ohnishi, Y | 1 |
| Yamamura, M | 1 |
| Asano, Y | 1 |
| Tanaka, H | 1 |
| Ikeda, K | 1 |
| Oda, E | 1 |
| Myoken, Y | 2 |
| Sugata, T | 1 |
| Kyo, T | 1 |
| Fujihara, M | 1 |
| Mikami, Y | 1 |
| Peggs, KS | 1 |
| Preiser, W | 1 |
| Kottaridis, PD | 1 |
| McKeag, N | 1 |
| Brink, NS | 1 |
| Tedder, RS | 1 |
| Goldstone, AH | 1 |
| Linch, DC | 1 |
| Mackinnon, S | 1 |
| De Beule, F | 1 |
| Bercy, P | 1 |
| Ferrant, A | 1 |
| Toyama, K | 1 |
| Lin, KY | 1 |
| Hojo, H | 1 |
| Tsuda, A | 1 |
| Torii, Y | 1 |
| Yoshikawa, O | 1 |
5 trials available for fluconazole and Lymphoma
| Article | Year |
|---|---|
Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Topics: Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Bacteremia; Candidi | 1995 |
[A comparative clinical study on flucytosine alone and in combination with fluconazole in hematological malignancies: a multicenter study using the envelope method].
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Glucans | 1994 |
Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Clotrimazole; Female; Fluconazole; Humans; Leukemia; | 1994 |
[A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children].
Topics: Candidiasis; Child; Female; Fluconazole; Fungemia; Humans; Immune Tolerance; Immunologic Deficiency | 1994 |
[Clinical study of fluconazole for systemic fungal infections with hematological disorders].
Topics: Adolescent; Adult; Aged; Child; Female; Fluconazole; Humans; Leukemia; Lymphoma; Male; Middle Aged; | 1993 |
17 other studies available for fluconazole and Lymphoma
| Article | Year |
|---|---|
Not What It Seems: Obstructive Jaundice in an HIV-Positive Patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Diagnosis, Diffe | 2021 |
The risk and clinical outcome of candidemia depending on underlying malignancy.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidemia; Critical Illness; Female; Fluconazole; Humans; | 2017 |
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug | 2018 |
Disseminated coccidioidomycosis masquerading as recurrent lymphoma.
Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Fluconazole; G | 2018 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross | 2012 |
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Clinical presentation and diagnosis of toxoplasmic encephalitis in Japan.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antiprotozoal Agents; Brain; Central N | 2014 |
A young man evaluated for suspicion of lymphoma.
Topics: Antifungal Agents; Biopsy; California; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Fl | 2014 |
[Efficacy of fluconazole on systemic mycosis associated with hematologic malignancies and a study on diagnostic value of plasma beta-D-glucan levels].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Glucans; Biomarkers; Drug Evaluation; Female; Fluco | 1993 |
The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.
Topics: Adolescent; Adult; Aged; Candidiasis, Oral; Female; Fluconazole; Humans; Leukemia, Myeloid; Lymphoma | 1993 |
Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Topics: Candida; Candidiasis; Catheterization, Central Venous; Disease Susceptibility; Drug Resistance, Micr | 1996 |
[Clinical efficacy of fluconazole against fungal infections in hematological diseases].
Topics: Adult; Antifungal Agents; Female; Fluconazole; Fungemia; Humans; Injections, Intravenous; Leukemia; | 1996 |
[A clinical evaluation of fluconazole in deep seated fungal infections associated with hematological disorders].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Fluconazole; Humans; Leukemia; Lymphoma; Male; M | 1996 |
Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Aspergillus; D | 1999 |
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cycl | 2000 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Imm | 1991 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Dr | 1989 |